Home
Contact Us
Register for the 2025 ACLA Annual Meeting
facebook
twitter
linkedin
menu
Menu
About Us
Show sub menu
arrow-down
Mission
Members
Board of Directors
Staff
Work at ACLA
Economic Impact
Issues
Show sub menu
arrow-down
PAMA Reform
Public Health Preparedness and Infrastructure
Regulatory Issues
Reimbursement & Coverage
Value of Clinical Labs: The Power of Knowing
Take Action
Newsroom
Show sub menu
arrow-down
ACLA Blog
ACLA Press Releases
Comments and Letters
Spotlight on Lab Professionals
All News
COVID-19
Member Resources
Show sub menu
arrow-down
ACLA’s 2024 Advocacy Agenda
CPT Committee
Close Menu
cross
Home
Contact Us
Register for the 2025 ACLA Annual Meeting
About Us
Show sub menu
arrow-down
Mission
Members
Board of Directors
Staff
Work at ACLA
Economic Impact
Issues
Show sub menu
arrow-down
PAMA Reform
Public Health Preparedness and Infrastructure
Regulatory Issues
Reimbursement & Coverage
Value of Clinical Labs: The Power of Knowing
Take Action
Newsroom
Show sub menu
arrow-down
ACLA Blog
ACLA Press Releases
Comments and Letters
Spotlight on Lab Professionals
All News
COVID-19
Member Resources
Show sub menu
arrow-down
ACLA’s 2024 Advocacy Agenda
CPT Committee
Home
|
All News
|
Comments and Letters
|
ACLA Comments on Medicare Coverage of Innovative Technology (MCIT)
ACLA Comments on Medicare Coverage of Innovative Technology (MCIT)
April 06, 2021
Categories:
Comments and Letters
,
Reimbursement and Coverage
,
Regulatory Issues
Download (PDF, 600KB)
Print page / Save as PDF
